Neogen Corporation NEOG
13.76
0.10
0.73%
as of 25 Sep
- Market cap
- $3.0B
- P/E
- 0.0×
Follow NEOG
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Aug '25 | Nov '25 | Feb '26 | May '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.38 | 1.46 | 2.79 | 2.23 | |
P/FCF ratio |
0.00 | 0.00 | 385.29 | 60.63 | |
P/Operating CF |
112.88 | 66.19 | 106.92 | 64.24 | |
P/B ratio |
0.58 | 0.61 | 1.15 | 0.93 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.14 | 2.22 | 3.54 | 2.95 | |
EV/EBITDA |
16.20 | 19.72 | 35.22 | 25.10 | |
EV/Operating CF |
21.83 | 29.53 | 44.38 | 30.86 | |
EV/FCF |
(745.80) | (109.37) | 488.90 | 80.24 | |
Quick Ratio |
1.90 | 1.89 | 1.97 | 2.10 | |
Current Ratio |
3.58 | 3.91 | 3.92 | 3.82 | |
Net Debt/EBITDA |
48.41 | 26.95 | 24.27 | 15.73 | |
Debt/Assets |
23.46% | 23.60% | 23.62% | 23.72% | |
Debt/Equity |
0.37 | 0.38 | 0.38 | 0.38 | |
Asset Turnover |
0.23 | 0.24 | 0.24 | 0.26 | |
Operating CF/Net income |
0.30 | (1.22) | (1.34) | (2.67) | |
Capex/Depreciation |
(0.81) | (0.40) | (0.39) | (0.11) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.45% | 2.03% | 1.80% | 2.18% | |
Selling, General and Administrative Expense of Revenue |
50.64% | 47.84% | 46.64% | 44.28% | |
Intangible Assets out of Total Assets |
0.73 | 0.72 | 0.71 | 0.71 | |
Share Based Compensation of Revenue |
2.37% | 1.93% | 0.52% | 1.33% | |
Graham Net Nets |
(0.60) | (0.53) | (0.27) | (0.33) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(85.11%) | (46.79%) | (25.11%) | (0.34%) | |
Free Cash Flow Yield |
(0.21%) | (1.39%) | 0.26% | 1.65% | |
Revenue per Share |
0.96 | 1.03 | 0.97 | 1.04 | |
Operating CF per Share |
0.05 | 0.09 | 0.10 | 0.14 | |
Capex per Share |
(0.11) | (0.05) | (0.05) | (0.02) | |
Free Cash Flow per Share |
(0.06) | 0.04 | 0.05 | 0.12 | |
Cash per Share |
0.64 | 0.67 | 0.73 | 0.85 | |
Shareholders Equity per Share |
9.75 | 9.68 | 9.66 | 9.62 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
9.75 | 9.68 | 9.66 | 9.62 | |
Free Cash Flow |
(13.15) | 7.78 | 11.17 | 26.20 | |
Working Capital |
377.86 | 427.53 | 439.40 | 446.40 | |
Capital Expenditures |
(24.00) | (11.67) | (11.53) | (4.00) | |
Net Current Asset Value |
(735.45) | (680.89) | (666.60) | (648.50) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.11 | 0.05 | 0.05 | 0.02 | |
Net Profit Margin |
17.37% | (7.09%) | (8.05%) | (5.02%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
153.05 | 148.04 | 148.58 | 150.10 | |
Average Payables |
69.03 | 71.31 | 73.72 | 79.35 | |
Average Inventory |
196.01 | 180.52 | 183.57 | 167.55 | |
Average Assets |
3,940.66 | 3,707.02 | 3,697.67 | 3,394.90 | |
Average Common Equity |
2,626.92 | 2,386.78 | 2,381.37 | 2,082.05 |
Columns are period end dates